TEM Logo

TEM Stock Forecast: Tempus AI Inc. Price Predictions for 2025

Home Stocks United States | NASDAQ | Healthcare | Health Information Services

$47.17

+5.01 (11.87%)

TEM Stock Forecast 2025-2026

$47.17
Current Price
$8.07B
Market Cap
11 Ratings
Buy 5
Hold 6
Sell 0
Wall St Analyst Ratings

Distance to TEM Price Targets

+56.9%
To High Target of $74.00
+37.8%
To Median Target of $65.00
+16.6%
To Low Target of $55.00

TEM Price Momentum

-3.9%
1 Week Change
-47.3%
1 Month Change
0.0%
1 Year Change
+39.7%
Year-to-Date Change
-48.4%
From 52W High of $91.45
+106.1%
From 52W Low of $22.89

🤔 Considering Tempus AI (TEM)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Latest TEM Stock Price Targets & Analyst Predictions

Based on our analysis of 11 Wall Street analysts, TEM has a neutral consensus with a median price target of $65.00 (ranging from $55.00 to $74.00). The overall analyst rating is Buy (7.5/10). Currently trading at $47.17, the median forecast implies a 37.8% upside. This outlook is supported by 5 Buy, 6 Hold, and 0 Sell ratings.

The most optimistic forecast comes from Dan Brennan at TD Cowen, projecting a 56.9% upside. Conversely, the most conservative target is provided by David Westenberg at Piper Sandler, suggesting a 16.6% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

TEM Analyst Ratings

5
Buy
6
Hold
0
Sell

TEM Price Target Range

Low
$55.00
Average
$65.00
High
$74.00
Current: $47.17

Latest TEM Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for TEM.

Date Firm Analyst Rating Change Price Target
Mar 6, 2025 Morgan Stanley Tejas Savant Overweight Maintains $60.00
Mar 4, 2025 Piper Sandler David Westenberg Neutral Maintains $55.00
Mar 3, 2025 B of A Securities Michael Ryskin Neutral Maintains $60.00
Feb 25, 2025 Needham Ryan MacDonald Buy Maintains $70.00
Feb 25, 2025 JP Morgan Rachel Vatnsdal Neutral Downgrade $55.00
Feb 25, 2025 Guggenheim Subbu Nambi Buy Reiterates $0.00
Feb 12, 2025 William Blair Andrew Brackmann Market Perform Downgrade $0.00
Feb 5, 2025 TD Cowen Dan Brennan Buy Reinstates $74.00
Jan 14, 2025 Needham Ryan MacDonald Buy Reiterates $56.00
Jan 14, 2025 Loop Capital Mark Schappel Buy Maintains $52.00
Dec 13, 2024 Wolfe Research Outperform Initiates $0.00
Dec 13, 2024 B of A Securities Neutral Maintains $0.00
Dec 9, 2024 Guggenheim Subbu Nambi Buy Initiates $74.00
Nov 12, 2024 Piper Sandler David Westenberg Neutral Reiterates $70.00
Nov 11, 2024 Stifel Daniel Arias Hold Downgrade $65.00
Oct 15, 2024 Loop Capital Mark Schappel Buy Maintains $57.00
Oct 2, 2024 B of A Securities Michael Ryskin Neutral Downgrade $60.00
Aug 12, 2024 Piper Sandler David Westenberg Neutral Initiates $40.00
Aug 7, 2024 Needham Ryan MacDonald Buy Reiterates $47.00
Aug 7, 2024 JP Morgan Rachel Vatnsdal Overweight Maintains $47.00

Tempus AI Inc. (TEM) Competitors

The following stocks are similar to Tempus AI based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Tempus AI Inc. (TEM) Financial Data

Tempus AI Inc. has a market capitalization of $8.07B with a P/E ratio of 0.0x. The company generates $693.40M in trailing twelve-month revenue with a -101.8% profit margin.

Revenue growth is +35.8% quarter-over-quarter, while maintaining an operating margin of -25.3% and return on equity of -1,324.7%.

Valuation Metrics

Market Cap $8.07B
Enterprise Value $7.28B
P/E Ratio 0.0x
PEG Ratio -66.9x
Price/Sales 11.6x

Growth & Margins

Revenue Growth (YoY) +35.8%
Gross Margin +60.8%
Operating Margin -25.3%
Net Margin -101.8%
EPS Growth +35.8%

Financial Health

Cash/Price Ratio +5.5%
Current Ratio 2.3x
Debt/Equity 830.9x
ROE -1,324.7%
ROA -58.0%

🔥 Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Tempus AI Inc. logo

Tempus AI Inc. (TEM) Business Model

About Tempus AI Inc.

What They Do

Develops AI solutions for operational efficiency.

Business Model

Tempus AI Inc. operates by creating customized artificial intelligence platforms that help organizations optimize their decision-making and operational processes. The company generates revenue through software licensing, consulting services, and ongoing support for its AI solutions across various sectors including healthcare, finance, and logistics.

Additional Information

With a strong focus on innovation, Tempus AI Inc. is well-positioned in the tech market, influencing industry standards for AI deployment. Its expertise in machine learning, natural language processing, and computer vision allows it to offer comprehensive tools that drive significant advancements in business efficiency and strategic outcomes.

Company Information

Sector

Healthcare

Industry

Health Information Services

Employees

2,400

CEO

Mr. Eric P. Lefkofsky

Country

United States

IPO Year

2024

Tempus AI Inc. (TEM) Latest News & Analysis

TEM stock latest news image
Quick Summary

Tempus AI, Inc. (NASDAQ: TEM) has acquired Deep 6 AI, enhancing its AI capabilities in precision medicine by improving clinical trial processes and real-world evidence generation.

Why It Matters

Tempus AI's acquisition of Deep 6 AI enhances its capabilities in precision medicine, potentially increasing its market share and value by improving clinical trial efficiency and real-world evidence generation.

Source: Business Wire
Market Sentiment: Neutral
TEM stock latest news image
Quick Summary

TEM has acquired Deep 6 AI to improve its AI-driven clinical trial matching, aiming to enhance patient recruitment and advance precision medicine.

Why It Matters

TEM's acquisition of Deep 6 AI boosts its AI capabilities, potentially increasing efficiency in clinical trials, which could lead to higher revenue and competitive advantage in precision medicine.

Source: Zacks Investment Research
Market Sentiment: Neutral
TEM stock latest news image
Quick Summary

Tempus AI (TEM) has seen a decline of 11.18% as it focuses on using artificial intelligence to enhance healthcare outcomes.

Why It Matters

Tempus AI's use of artificial intelligence in healthcare could enhance operational efficiencies and improve patient outcomes, potentially increasing market competitiveness and driving future revenue growth.

Source: The Motley Fool
Market Sentiment: Neutral
TEM stock latest news image
Quick Summary

Tempus AI Inc (TEM) will report Q4 earnings on Monday, with Wall Street anticipating a loss of 20 cents per share and revenues of $203.12 million, after market hours.

Why It Matters

Tempus AI Inc's upcoming earnings report could impact stock prices based on actual results versus expectations of a loss and revenue figures, influencing investor sentiment and trading decisions.

Source: Benzinga
Market Sentiment: Positive
TEM stock latest news image
Quick Summary

Tempus AI stock declined after the company released its fourth-quarter financial results on Monday.

Why It Matters

Tempus AI's stock decline signals potential concerns over its financial health and growth prospects, impacting investor confidence and future valuation.

Source: Investors Business Daily
Market Sentiment: Negative
TEM stock latest news image
Quick Summary

Tempus AI (NASDAQ:TEM) shares are down over 13% in morning trading following its Q4 and full-year 2024 earnings report released after market close.

Why It Matters

Tempus AI's 13% share drop signals investor concern over its earnings, potentially affecting market confidence and future valuations in the AI sector.

Source: 24/7 Wall Street
Market Sentiment: Negative

Frequently Asked Questions About TEM Stock

What is Tempus AI Inc.'s (TEM) stock forecast for 2025?

Based on our analysis of 11 Wall Street analysts, Tempus AI Inc. (TEM) has a median price target of $65.00. The highest price target is $74.00 and the lowest is $55.00.

Is TEM stock a good investment in 2025?

According to current analyst ratings, TEM has 5 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $47.17. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for TEM stock?

Wall Street analysts predict TEM stock could reach $65.00 in the next 12 months. This represents a 37.8% increase from the current price of $47.17. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Tempus AI Inc.'s business model?

Tempus AI Inc. operates by creating customized artificial intelligence platforms that help organizations optimize their decision-making and operational processes. The company generates revenue through software licensing, consulting services, and ongoing support for its AI solutions across various sectors including healthcare, finance, and logistics.

What is the highest forecasted price for TEM Tempus AI Inc.?

The highest price target for TEM is $74.00 from Dan Brennan at TD Cowen, which represents a 56.9% increase from the current price of $47.17.

What is the lowest forecasted price for TEM Tempus AI Inc.?

The lowest price target for TEM is $55.00 from David Westenberg at Piper Sandler, which represents a 16.6% increase from the current price of $47.17.

What is the overall TEM consensus from analysts for Tempus AI Inc.?

The overall analyst consensus for TEM is neutral. Out of 11 Wall Street analysts, 5 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $65.00.

How accurate are TEM stock price projections?

Stock price projections, including those for Tempus AI Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: March 16, 2025 8:57 AM UTC